Industry: Medical Devices & Consumables
Published Date: 2024-06-15
Pages: 119 Pages
Report ld: 3200851
Request Sample
Customized Report
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
The global Cell Therapy Manufacturing Platform revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Cell Therapy Manufacturing Platform revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Cell Therapy Manufacturing Platform market, also covers the segmentation data of other regions in regional level and county level.
The Cell Therapy Manufacturing Platform Market is experiencing robust growth, driven by advancements in biotechnology and increasing investment in regenerative medicine. Major sales regions include North America, Europe, and Asia-Pacific, with the U.S. and China leading due to their strong biopharmaceutical sectors and supportive regulatory environments. Market opportunities are abundant, particularly in personalized medicine and cancer treatment, where cell therapies show significant promise. However, the market faces challenges such as high manufacturing costs, complex production processes, and stringent regulatory requirements. Overcoming these hurdles is crucial for the broader adoption and commercialization of cell therapies, which are poised to revolutionize modern healthcare.
Global Cell Therapy Manufacturing Platform Scope and Market Size
Cell Therapy Manufacturing Platform market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Cell Therapy Manufacturing Platform market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Cell Therapy Manufacturing Platform market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Cell Therapy Manufacturing Platform definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Cell Therapy Manufacturing Platform companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Cell Therapy Manufacturing Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapy Manufacturing Platform revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Cell Therapy Manufacturing Platform Product Introduction
1.2 Global Cell Therapy Manufacturing Platform Outlook, 2019 VS 2023 VS 2030
1.2.1 Global Cell Therapy Manufacturing Platform Market Size for the Year 2019-2030
1.2.2 United States Cell Therapy Manufacturing Platform Market Size for the Year 2019-2030
1.3 Cell Therapy Manufacturing Platform Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States Cell Therapy Manufacturing Platform in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of Cell Therapy Manufacturing Platform Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 Cell Therapy Manufacturing Platform Market Dynamics
1.4.1 Cell Therapy Manufacturing Platform Industry Trends
1.4.2 Cell Therapy Manufacturing Platform Market Drivers
1.4.3 Cell Therapy Manufacturing Platform Market Challenges
1.4.4 Cell Therapy Manufacturing Platform Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Cell Therapy Manufacturing Platform by Type
2.1 Cell Therapy Manufacturing Platform Market by Type
2.1.1 Autologous Cell Therapies
2.1.2 Allogeneic Cell Therapies
2.2 Global Cell Therapy Manufacturing Platform Market Size by Type (2019, 2023 & 2030)
2.3 Global Cell Therapy Manufacturing Platform Market Size by Type (2019-2030)
2.4 United States Cell Therapy Manufacturing Platform Market Size by Type (2019, 2023 & 2030)
2.5 United States Cell Therapy Manufacturing Platform Market Size by Type (2019-2030)
3 Cell Therapy Manufacturing Platform by Application
3.1 Cell Therapy Manufacturing Platform Market by Application
3.1.1 Oncology
3.1.2 Cardiovascular Diseases
3.1.3 Neurological Disorders
3.1.4 Musculoskeletal Disorders
3.1.5 Others
3.2 Global Cell Therapy Manufacturing Platform Market Size, by Application (2019, 2023 & 2030)
3.3 Global Cell Therapy Manufacturing Platform Market Size by Application (2019-2030)
3.4 United States Cell Therapy Manufacturing Platform Market Size by Application (2019, 2023 & 2030)
3.5 United States Cell Therapy Manufacturing Platform Market Size by Application (2019-2030)
4 Global Cell Therapy Manufacturing Platform Competitor Landscape by Company
4.1 Global Cell Therapy Manufacturing Platform Market Size by Company
4.1.1 Global Key Companies of Cell Therapy Manufacturing Platform, Ranked by Revenue (2023)
4.1.2 Global Cell Therapy Manufacturing Platform Revenue by Player (2019-2024)
4.2 Global Cell Therapy Manufacturing Platform Concentration Ratio (CR)
4.2.1 Cell Therapy Manufacturing Platform Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Cell Therapy Manufacturing Platform in 2023
4.2.3 Global Cell Therapy Manufacturing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Cell Therapy Manufacturing Platform Head office and Area Served
4.4 Global Key Players of Cell Therapy Manufacturing Platform, Product and Application
4.5 Global Key Players of Cell Therapy Manufacturing Platform, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Cell Therapy Manufacturing Platform Market Size by Company
4.7.1 Key Players of Cell Therapy Manufacturing Platform in United States, Ranked by Revenue (2023)
4.7.2 United States Cell Therapy Manufacturing Platform Revenue by Players (2022, 2023 & 2024)
5 Global Cell Therapy Manufacturing Platform Market Size by Region
5.1 Global Cell Therapy Manufacturing Platform Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Cell Therapy Manufacturing Platform Market Size by Region (2019-2030)
5.2.1 Global Cell Therapy Manufacturing Platform Market Size by Region: 2019-2024
5.2.2 Global Cell Therapy Manufacturing Platform Market Size by Region: 2025-2030
6 Americas
6.1 Americas Cell Therapy Manufacturing Platform Market Size YoY Growth 2019-2030
6.2 Americas Cell Therapy Manufacturing Platform Market Size by Type
6.2.1 Americas Cell Therapy Manufacturing Platform Market Size by Type (2019-2024)
6.2.2 Americas Cell Therapy Manufacturing Platform Market Size by Type (2025-2030)
6.2.3 Americas Cell Therapy Manufacturing Platform Market Share by Type (2019-2030)
6.3 Americas Cell Therapy Manufacturing Platform Market Size by Application
6.3.1 Americas Cell Therapy Manufacturing Platform Market Size by Application (2019-2024)
6.3.2 Americas Cell Therapy Manufacturing Platform Market Size by Application (2025-2030)
6.3.3 Americas Cell Therapy Manufacturing Platform Market Share by Application (2019-2030)
6.4 Americas Cell Therapy Manufacturing Platform Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Cell Therapy Manufacturing Platform Market Size YoY Growth 2019-2030
7.2 EMEA Cell Therapy Manufacturing Platform Market Size by Type
7.2.1 EMEA Cell Therapy Manufacturing Platform Market Size by Type (2019-2024)
7.2.2 EMEA Cell Therapy Manufacturing Platform Market Size by Type (2025-2030)
7.2.3 EMEA Cell Therapy Manufacturing Platform Market Share by Type (2019-2030)
7.3 EMEA Cell Therapy Manufacturing Platform Market Size by Application
7.3.1 EMEA Cell Therapy Manufacturing Platform Market Size by Application (2019-2024)
7.3.2 EMEA Cell Therapy Manufacturing Platform Market Size by Application (2025-2030)
7.3.3 EMEA Cell Therapy Manufacturing Platform Market Share by Application (2019-2030)
7.4 EMEA Cell Therapy Manufacturing Platform Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Cell Therapy Manufacturing Platform Market Size by Type
8.1.1 China Cell Therapy Manufacturing Platform Market Size by Type (2019-2024)
8.1.2 China Cell Therapy Manufacturing Platform Market Size by Type (2025-2030)
8.1.3 China Cell Therapy Manufacturing Platform Market Share by Type (2019-2030)
8.2 China Cell Therapy Manufacturing Platform Market Size by Application
8.2.1 China Cell Therapy Manufacturing Platform Market Size by Application (2019-2024)
8.2.2 China Cell Therapy Manufacturing Platform Market Size by Application (2025-2030)
8.2.3 China Cell Therapy Manufacturing Platform Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Cell Therapy Manufacturing Platform Market Size YoY Growth 2019-2030
9.2 APAC Cell Therapy Manufacturing Platform Market Size by Type
9.2.1 APAC Cell Therapy Manufacturing Platform Market Size by Type (2019-2024)
9.2.2 APAC Cell Therapy Manufacturing Platform Market Size by Type (2025-2030)
9.2.3 APAC Cell Therapy Manufacturing Platform Market Share by Type (2019-2030)
9.3 APAC Cell Therapy Manufacturing Platform Market Size by Application
9.3.1 APAC Cell Therapy Manufacturing Platform Market Size by Application (2019-2024)
9.3.2 APAC Cell Therapy Manufacturing Platform Market Size by Application (2025-2030)
9.3.3 APAC Cell Therapy Manufacturing Platform Market Share by Application (2019-2030)
9.4 APAC Cell Therapy Manufacturing Platform Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 Cellares
10.1.1 Cellares Company Details
10.1.2 Cellares Business Overview
10.1.3 Cellares Cell Therapy Manufacturing Platform Introduction
10.1.4 Cellares Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.1.5 Cellares Recent Development
10.2 Miltenyi Biotec
10.2.1 Miltenyi Biotec Company Details
10.2.2 Miltenyi Biotec Business Overview
10.2.3 Miltenyi Biotec Cell Therapy Manufacturing Platform Introduction
10.2.4 Miltenyi Biotec Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.2.5 Miltenyi Biotec Recent Development
10.3 Cytiva
10.3.1 Cytiva Company Details
10.3.2 Cytiva Business Overview
10.3.3 Cytiva Cell Therapy Manufacturing Platform Introduction
10.3.4 Cytiva Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.3.5 Cytiva Recent Development
10.4 Lonza
10.4.1 Lonza Company Details
10.4.2 Lonza Business Overview
10.4.3 Lonza Cell Therapy Manufacturing Platform Introduction
10.4.4 Lonza Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.4.5 Lonza Recent Development
10.5 Adva Biotechnology
10.5.1 Adva Biotechnology Company Details
10.5.2 Adva Biotechnology Business Overview
10.5.3 Adva Biotechnology Cell Therapy Manufacturing Platform Introduction
10.5.4 Adva Biotechnology Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.5.5 Adva Biotechnology Recent Development
10.6 BioNTech
10.6.1 BioNTech Company Details
10.6.2 BioNTech Business Overview
10.6.3 BioNTech Cell Therapy Manufacturing Platform Introduction
10.6.4 BioNTech Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.6.5 BioNTech Recent Development
10.7 3M
10.7.1 3M Company Details
10.7.2 3M Business Overview
10.7.3 3M Cell Therapy Manufacturing Platform Introduction
10.7.4 3M Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.7.5 3M Recent Development
10.8 Ori Biotech
10.8.1 Ori Biotech Company Details
10.8.2 Ori Biotech Business Overview
10.8.3 Ori Biotech Cell Therapy Manufacturing Platform Introduction
10.8.4 Ori Biotech Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.8.5 Ori Biotech Recent Development
10.9 Limula
10.9.1 Limula Company Details
10.9.2 Limula Business Overview
10.9.3 Limula Cell Therapy Manufacturing Platform Introduction
10.9.4 Limula Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.9.5 Limula Recent Development
10.10 Resilience
10.10.1 Resilience Company Details
10.10.2 Resilience Business Overview
10.10.3 Resilience Cell Therapy Manufacturing Platform Introduction
10.10.4 Resilience Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.10.5 Resilience Recent Development
10.11 Cellistic
10.11.1 Cellistic Company Details
10.11.2 Cellistic Business Overview
10.11.3 Cellistic Cell Therapy Manufacturing Platform Introduction
10.11.4 Cellistic Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.11.5 Cellistic Recent Development
10.12 Catalent
10.12.1 Catalent Company Details
10.12.2 Catalent Business Overview
10.12.3 Catalent Cell Therapy Manufacturing Platform Introduction
10.12.4 Catalent Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.12.5 Catalent Recent Development
10.13 Criver
10.13.1 Criver Company Details
10.13.2 Criver Business Overview
10.13.3 Criver Cell Therapy Manufacturing Platform Introduction
10.13.4 Criver Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.13.5 Criver Recent Development
10.14 ElevateBio
10.14.1 ElevateBio Company Details
10.14.2 ElevateBio Business Overview
10.14.3 ElevateBio Cell Therapy Manufacturing Platform Introduction
10.14.4 ElevateBio Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.14.5 ElevateBio Recent Development
10.15 Ultragenyx
10.15.1 Ultragenyx Company Details
10.15.2 Ultragenyx Business Overview
10.15.3 Ultragenyx Cell Therapy Manufacturing Platform Introduction
10.15.4 Ultragenyx Revenue in Cell Therapy Manufacturing Platform Business (2019-2024)
10.15.5 Ultragenyx Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Cell Therapy Manufacturing Platform market is projected to grow from US$ 5647 million in 2025 to US$ 12810 million by 2032, at a CAGR of 12.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 142
USD 4900.00
(Single User License)
The global Cell Therapy Manufacturing Platform market size was US$ 5647 million in 2025 and is forecast to reach a readjusted size of US$ 12810 million by 2032 with a CAGR of 12.6% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 94
USD 4250.00
(Single User License)
The global market for Cell Therapy Manufacturing Platform was estimated to be worth US$ 5647 million in 2025 and is projected to reach US$ 12810 million, growing at a CAGR of 12.6% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 110
USD 3950.00
(Single User License)
The global Cell Therapy Manufacturing Platform market was valued at US$ 5647 million in 2025 and is anticipated to reach US$ 12810 million by 2032, at a CAGR of 12.6% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 111
USD 2900.00
(Single User License)
The global Cell Therapy Manufacturing Platform market is projected to grow from US$ 5016 million in 2024 to US$ 11509 million by 2031, at a CAGR of 12.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-22
Pages: 144
USD 4900.00
(Single User License)
The global Cell Therapy Manufacturing Platform market size was US$ 5016 million in 2024 and is forecast to a readjusted size of US$ 11509 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published Date: 2025-10-22
Pages: 98
USD 4250.00
(Single User License)
The global market for Cell Therapy Manufacturing Platform was estimated to be worth US$ 5016 million in 2024 and is forecast to a readjusted size of US$ 11509 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published Date: 2025-10-22
Pages: 120
USD 3950.00
(Single User License)
The global market for Cell Therapy Manufacturing Platform was valued at US$ 5016 million in the year 2024 and is projected to reach a revised size of US$ 11509 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Published Date: 2025-10-22
Pages: 81
USD 2900.00
(Single User License)
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published Date: 2024-06-15
Pages: 141
USD 4900.00
(Single User License)
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published Date: 2024-06-15
Pages: 88
USD 2900.00
(Single User License)
The global Cell Therapy Manufacturing Platform market is projected to grow from US$ 5647 million in 2025 to US$ 12810 million by 2032, at a CAGR of 12.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 142
The global Cell Therapy Manufacturing Platform market size was US$ 5647 million in 2025 and is forecast to reach a readjusted size of US$ 12810 million by 2032 with a CAGR of 12.6% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 94
The global market for Cell Therapy Manufacturing Platform was estimated to be worth US$ 5647 million in 2025 and is projected to reach US$ 12810 million, growing at a CAGR of 12.6% from 2026 to 2032.
Published: 2026-01-19
Pages: 110
The global Cell Therapy Manufacturing Platform market was valued at US$ 5647 million in 2025 and is anticipated to reach US$ 12810 million by 2032, at a CAGR of 12.6% from 2026 to 2032.
Published: 2026-01-14
Pages: 111
The global Cell Therapy Manufacturing Platform market is projected to grow from US$ 5016 million in 2024 to US$ 11509 million by 2031, at a CAGR of 12.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-22
Pages: 144
The global Cell Therapy Manufacturing Platform market size was US$ 5016 million in 2024 and is forecast to a readjusted size of US$ 11509 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published: 2025-10-22
Pages: 98
The global market for Cell Therapy Manufacturing Platform was estimated to be worth US$ 5016 million in 2024 and is forecast to a readjusted size of US$ 11509 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published: 2025-10-22
Pages: 120
The global market for Cell Therapy Manufacturing Platform was valued at US$ 5016 million in the year 2024 and is projected to reach a revised size of US$ 11509 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Published: 2025-10-22
Pages: 81
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published: 2024-06-15
Pages: 141
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published: 2024-06-15
Pages: 88
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now